Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1038/s41591-020-01202-8

http://scihub22266oqcxt.onion/10.1038/s41591-020-01202-8
suck pdf from google scholar
33442016!ä!33442016

suck abstract from ncbi


Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33442016      Nat+Med 2021 ; 27 (1): 28-33
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Immune determinants of COVID-19 disease presentation and severity #MMPMID33442016
  • Brodin P
  • Nat Med 2021[Jan]; 27 (1): 28-33 PMID33442016show ga
  • COVID-19, caused by SARS-CoV-2 infection, is mild to moderate in the majority of previously healthy individuals, but can cause life-threatening disease or persistent debilitating symptoms in some cases. The most important determinant of disease severity is age, with individuals over 65 years having the greatest risk of requiring intensive care, and men are more susceptible than women. In contrast to other respiratory viral infections, young children seem to be less severely affected. It is now clear that mild to severe acute infection is not the only outcome of COVID-19, and long-lasting symptoms are also possible. In contrast to severe acute COVID-19, such 'long COVID' is seemingly more likely in women than in men. Also, postinfectious hyperinflammatory disease has been described as an additional outcome after SARS-CoV-2 infection. Here I discuss our current understanding of the immunological determinants of COVID-19 disease presentation and severity and relate this to known immune-system differences between young and old people and between men and women, and other factors associated with different disease presentations and severity.
  • |Adaptive Immunity[MESH]
  • |Adult[MESH]
  • |Age Factors[MESH]
  • |Aged[MESH]
  • |COVID-19/complications/epidemiology/etiology/*immunology/*physiopathology[MESH]
  • |Child[MESH]
  • |Female[MESH]
  • |Humans[MESH]
  • |Immunity, Innate[MESH]
  • |Immunologic Deficiency Syndromes/chemically induced/immunology/virology[MESH]
  • |Male[MESH]
  • |SARS-CoV-2/immunology/*physiology[MESH]
  • |Severity of Illness Index[MESH]
  • |Sex Factors[MESH]
  • |Systemic Inflammatory Response Syndrome/etiology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box